MedTrace Logo

Microbiology Testing With the Aim Of Directed Antimicrobial Therapy For CAP

NCT01662258 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2016-04-19

No results posted yet for this study

Summary

This is a prospective interventional study to assess laboratory testing which will identify the microbial cause of pneumonia. This, in turn, will allow targeted antimicrobial agent selection for patients with community acquired-pneumonia (CAP).

Hypothesis: 1) To determine if Targeted strategy is non-inferior to Empiric therapy with respect to outcome endpoints. 2) To assess the use of innovative POC tests allows targeted narrow-spectrum antimicrobial therapy. 3) To determine if Targeted strategy is superior to Empiric therapy in patients with viral pneumonia

Conditions

  • Community-acquired Pneumonia

Interventions

DEVICE

Point-of-Care diagnostic laboratory test

All POC tests are FDA-cleared.

Sponsors & Collaborators

  • University of Louisville

    collaborator OTHER

  • Louisville VA Medical Center

    collaborator FED

  • Johns Hopkins University

    collaborator OTHER

  • Summa Health System

    collaborator OTHER

  • Baylor College of Medicine

    collaborator OTHER

  • Ben Taub Hospital

    collaborator OTHER

  • Michael E. DeBakey VA Medical Center

    collaborator FED

  • Beth Israel Medical Center

    collaborator OTHER

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Victor L Yu, M.D. · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01662258 on ClinicalTrials.gov